Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Andreas Kammerlander, Ph.D., M.D.

Title
Institution
Department
Address
Profile Picture

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Nitsche C, Aschauer S, Kammerlander AA, Schneider M, Poschner T, Duca F, Binder C, Koschutnik M, Stiftinger J, Goliasch G, Siller-Matula J, Winter MP, Anvari-Pirsch A, Andreas M, Geppert A, Beitzke D, Loewe C, Hacker M, Agis H, Kain R, Lang I, Bonderman D, Hengstenberg C, Mascherbauer J. Light-chain and transthyretin cardiac amyloidosis in severe aortic stenosis: prevalence, screening possibilities, and outcome. Eur J Heart Fail. 2020 Feb 20. PMID: 32078212.
    Citations:    
  2. Nitsche C, Koschutnik M, Kammerlander A, Hengstenberg C, Mascherbauer J. Gender-specific differences in valvular heart disease. Wien Klin Wochenschr. 2020 Feb; 132(3-4):61-68. PMID: 31997064.
    Citations:    
  3. Kammerlander AA. Feature Tracking by Cardiovascular Magnetic Resonance Imaging: The New Gold Standard for Systolic Function? JACC Cardiovasc Imaging. 2020 Jan 09. PMID: 31954649.
    Citations:    
  4. Schönbauer R, Duca F, Kammerlander AA, Aschauer S, Binder C, Zotter-Tufaro C, Koschutnik M, Fiedler L, Roithinger FX, Loewe C, Hengstenberg C, Bonderman D, Mascherbauer J. Persistent atrial fibrillation in heart failure with preserved ejection fraction: Prognostic relevance and association with clinical, imaging and invasive haemodynamic parameters. Eur J Clin Invest. 2020 Feb; 50(2):e13184. PMID: 31732964.
    Citations:    
  5. Dalos D, Binder C, Duca F, Aschauer S, Kammerlander A, Hengstenberg C, Mascherbauer J, Reiberger T, Bonderman D. Serum levels of gamma-glutamyltransferase predict outcome in heart failure with preserved ejection fraction. Sci Rep. 2019 Dec 06; 9(1):18541. PMID: 31811258.
    Citations:    
  6. Kammerlander AA, Mascherbauer J. The Authors Reply. JACC Cardiovasc Imaging. 2019 Nov; 12(11 Pt 1):2284. PMID: 31699354.
    Citations:    
  7. Nitsche C, Kammerlander AA, Binder C, Duca F, Aschauer S, Koschutnik M, Snidat A, Beitzke D, Loewe C, Bonderman D, Hengstenberg C, Mascherbauer J. Native T1 time of right ventricular insertion points by cardiac magnetic resonance: relation with invasive haemodynamics and outcome in heart failure with preserved ejection fraction. Eur Heart J Cardiovasc Imaging. 2019 Sep 08. PMID: 31495874.
    Citations:    
  8. Schrutka L, Seirer B, Duca F, Binder C, Dalos D, Kammerlander A, Aschauer S, Koller L, Benazzo A, Agibetov A, Gwechenberger M, Hengstenberg C, Mascherbauer J, Bonderman D. Patients with Heart Failure and Preserved Ejection Fraction Are at Risk of Gastrointestinal Bleeding. J Clin Med. 2019 Aug 17; 8(8). PMID: 31426462.
    Citations:    
  9. Binder C, Poglitsch M, Agibetov A, Duca F, Zotter-Tufaro C, Nitsche C, Aschauer S, Kammerlander AA, Oeztuerk B, Hengstenberg C, Mascherbauer J, Bonderman D. Angs (Angiotensins) of the Alternative Renin-Angiotensin System Predict Outcome in Patients With Heart Failure and Preserved Ejection Fraction. Hypertension. 2019 08; 74(2):285-294. PMID: 31230551.
    Citations:    
  10. Kammerlander AA. With a grain of salt: Sodium levels in heart failure. Int J Cardiol. 2019 09 01; 290:125-126. PMID: 31133432.
    Citations:    
  11. Binder C, Duca F, Stelzer PD, Nitsche C, Rettl R, Aschauer S, Kammerlander AA, Binder T, Agis H, Kain R, Hengstenberg C, Mascherbauer J, Bonderman D. Mechanisms of heart failure in transthyretin vs. light chain amyloidosis. Eur Heart J Cardiovasc Imaging. 2019 May 01; 20(5):512-524. PMID: 30649240.
    Citations:    
  12. Duca F, Aschauer S, Zotter-Tufaro C, Binder C, Kammerlander A, Börries B, Agis H, Kain R, Hengstenberg C, Mascherbauer J, Bonderman D. EXPRESS: Riociguat for the treatment of transthyretin cardiac amyloidosis - Data from a named patient use program in Austria. Pulm Circ. 2019 Apr 22; 2045894019849394. PMID: 31007127.
    Citations:    
  13. Kammerlander AA, Kraiger JA, Nitsche C, Donà C, Duca F, Zotter-Tufaro C, Binder C, Aschauer S, Loewe C, Hengstenberg C, Bonderman D, Mascherbauer J. Global Longitudinal Strain by CMR Feature Tracking Is Associated With Outcome in HFPEF. JACC Cardiovasc Imaging. 2019 Aug; 12(8 Pt 1):1585-1587. PMID: 31005535.
    Citations:    
  14. Kammerlander AA, Mascherbauer J. What is normal? A central question in the application of CMR mapping techniques. Wien Klin Wochenschr. 2019 04; 131(7-8):141-142. PMID: 30976977.
    Citations:    
  15. Nitsche C, Kammerlander AA, Knechtelsdorfer K, Kraiger JA, Goliasch G, Dona C, Schachner L, Öztürk B, Binder C, Duca F, Aschauer S, Zimpfer D, Bonderman D, Hengstenberg C, Mascherbauer J. Determinants of Bioprosthetic Aortic Valve Degeneration. JACC Cardiovasc Imaging. 2020 Feb; 13(2 Pt 1):345-353. PMID: 30878425.
    Citations:    
  16. Goliasch G, Kammerlander AA, Nitsche C, Dona C, Schachner L, Öztürk B, Binder C, Duca F, Aschauer S, Laufer G, Hengstenberg C, Bonderman D, Mascherbauer J. Syncope: The Underestimated Threat in Severe Aortic Stenosis. JACC Cardiovasc Imaging. 2019 02; 12(2):225-232. PMID: 30553685.
    Citations:    
  17. Kammerlander AA, Wiesinger M, Duca F, Aschauer S, Binder C, Zotter Tufaro C, Nitsche C, Badre-Eslam R, Schönbauer R, Bartko P, Beitzke D, Loewe C, Hengstenberg C, Bonderman D, Mascherbauer J. Diagnostic and Prognostic Utility of Cardiac Magnetic Resonance Imaging in Aortic Regurgitation. JACC Cardiovasc Imaging. 2019 08; 12(8 Pt 1):1474-1483. PMID: 30448117.
    Citations:    
  18. Duca F, Kammerlander AA, Panzenböck A, Binder C, Aschauer S, Loewe C, Agis H, Kain R, Hengstenberg C, Bonderman D, Mascherbauer J. Cardiac Magnetic Resonance T1 Mapping in Cardiac Amyloidosis. JACC Cardiovasc Imaging. 2018 12; 11(12):1924-1926. PMID: 30121265.
    Citations:    
  19. Antlanger M, Aschauer S, Kammerlander AA, Duca F, Säemann MD, Bonderman D, Mascherbauer J. Impact of Systemic Volume Status on Cardiac Magnetic Resonance T1 Mapping. Sci Rep. 2018 04 03; 8(1):5572. PMID: 29615750.
    Citations:    
  20. Wiedemann D, Rupprechter V, Mascherbauer J, Kammerlander A, Mora B, Dimitrov K, Weber B, Andreas M, Laufer G, Kocher A. Tricuspid valve replacement: results of an orphan procedure - which is the best prosthesis? J Cardiovasc Surg (Torino). 2018 Aug; 59(4):626-632. PMID: 29430890.
    Citations:    
  21. Duca F, Zotter-Tufaro C, Kammerlander AA, Aschauer S, Binder C, Mascherbauer J, Bonderman D. Gender-related differences in heart failure with preserved ejection fraction. Sci Rep. 2018 01 18; 8(1):1080. PMID: 29348420.
    Citations:    
  22. Mascherbauer J, Zotter-Tufaro C, Duca F, Binder C, Koschutnik M, Kammerlander AA, Aschauer S, Bonderman D. Wedge Pressure Rather Than Left Ventricular End-Diastolic Pressure Predicts Outcome in Heart Failure With Preserved Ejection Fraction. JACC Heart Fail. 2017 11; 5(11):795-801. PMID: 29032138.
    Citations:    
  23. Kammerlander AA, Duca F, Binder C, Aschauer S, Zotter-Tufaro C, Koschutnik M, Marzluf BA, Bonderman D, Mascherbauer J. Extracellular volume quantification by cardiac magnetic resonance imaging without hematocrit sampling : Ready for prime time? Wien Klin Wochenschr. 2018 Mar; 130(5-6):190-196. PMID: 28980127.
    Citations:    
  24. Kammerlander AA, Aschauer S, Zotter-Tufaro C, Duca F, Knechtelsdorfer K, Wiesinger M, Schwaiger ML, Dalos D, Schneider M, Marzluf BA, Bonderman D, Mascherbauer J. Diameter of the Pulmonary Artery in Relation to the Ascending Aorta: Association with Cardiovascular Outcome. Radiology. 2017 09; 284(3):685-693. PMID: 28562205.
    Citations:    
  25. Gelpi E, Susani M, Wiebringhaus R, Aschauer A, Kammerlander A, Lutz MI, Hainfellner JA. Clinical Neuropathology image 3-2017: CNS involvement in systemic amyloidosis restricted to the choroid plexus. Clin Neuropathol. 2017 May/Jun; 36 (2017)(3):100-101. PMID: 28436370.
    Citations:    
  26. Mascherbauer J, Kammerlander AA, Zotter-Tufaro C, Aschauer S, Duca F, Dalos D, Winkler S, Schneider M, Bergler-Klein J, Bonderman D. Presence of ´isolated´ tricuspid regurgitation should prompt the suspicion of heart failure with preserved ejection fraction. PLoS One. 2017; 12(2):e0171542. PMID: 28199339.
    Citations:    
  27. Koell B, Zotter-Tufaro C, Duca F, Kammerlander AA, Aschauer S, Dalos D, Antlanger M, Hecking M, Säemann M, Mascherbauer J, Bonderman D. Fluid status and outcome in patients with heart failure and preserved ejection fraction. Int J Cardiol. 2017 Mar 01; 230:476-481. PMID: 28062131.
    Citations:    
  28. Duca F, Kammerlander AA, Zotter-Tufaro C, Aschauer S, Schwaiger ML, Marzluf BA, Bonderman D, Mascherbauer J. Interstitial Fibrosis, Functional Status, and Outcomes in Heart Failure With Preserved Ejection Fraction: Insights From a Prospective Cardiac Magnetic Resonance Imaging Study. Circ Cardiovasc Imaging. 2016 Dec; 9(12). PMID: 27974408.
    Citations:    
  29. Duca F, Zotter-Tufaro C, Kammerlander AA, Panzenböck A, Aschauer S, Dalos D, Köll B, Börries B, Agis H, Kain R, Aumayr K, Klinglmüller F, Mascherbauer J, Bonderman D. Cardiac extracellular matrix is associated with adverse outcome in patients with chronic heart failure. Eur J Heart Fail. 2017 04; 19(4):502-511. PMID: 27891745.
    Citations:    
  30. Aschauer S, Zotter-Tufaro C, Duca F, Kammerlander A, Dalos D, Mascherbauer J, Bonderman D. Modes of death in patients with heart failure and preserved ejection fraction. Int J Cardiol. 2017 Feb 01; 228:422-426. PMID: 27870971.
    Citations:    
  31. Mascherbauer J, Grünig E, Halank M, Hohenforst-Schmidt W, Kammerlander AA, Pretsch I, Steringer-Mascherbauer R, Ulrich S, Lang IM, Wargenau M, Frey R, Bonderman D. Evaluation of the pharmacoDYNAMIC effects of riociguat in subjects with pulmonary hypertension and heart failure with preserved ejection fraction : Study protocol for a randomized controlled trial. Wien Klin Wochenschr. 2016 Dec; 128(23-24):882-889. PMID: 27590259.
    Citations:    
  32. Dalos D, Mascherbauer J, Zotter-Tufaro C, Duca F, Kammerlander AA, Aschauer S, Bonderman D. Functional Status, Pulmonary Artery Pressure, and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction. J Am Coll Cardiol. 2016 07 12; 68(2):189-99. PMID: 27386773.
    Citations:    
  33. Antlanger M, Kammerlander AA, Ullrich R, Haidinger M, Bonderman D, Mascherbauer J, Säemann MD. When it rains, it pours: Peripartum cardiomyopathy with features of left-ventricular noncompaction in a hemodialysis patient. Hemodial Int. 2016 10; 20(4):E14-E17. PMID: 27147549.
    Citations:    
  34. Goliasch G, Pavo N, Zotter-Tufaro C, Kammerlander A, Duca F, Mascherbauer J, Bonderman D. Soluble neprilysin does not correlate with outcome in heart failure with preserved ejection fraction. Eur J Heart Fail. 2016 Jan; 18(1):89-93. PMID: 26725876.
    Citations:    
  35. Kammerlander AA. [Not Available]. Wien Klin Wochenschr. 2016 Jan; 128(1-2):80-1. PMID: 26802033.
    Citations:    
  36. Kammerlander AA, Marzluf BA, Zotter-Tufaro C, Aschauer S, Duca F, Bachmann A, Knechtelsdorfer K, Wiesinger M, Pfaffenberger S, Greiser A, Lang IM, Bonderman D, Mascherbauer J. T1 Mapping by CMR Imaging: From Histological Validation to Clinical Implication. JACC Cardiovasc Imaging. 2016 Jan; 9(1):14-23. PMID: 26684970.
    Citations:    
  37. Aschauer S, Kammerlander AA, Zotter-Tufaro C, Ristl R, Pfaffenberger S, Bachmann A, Duca F, Marzluf BA, Bonderman D, Mascherbauer J. The right heart in heart failure with preserved ejection fraction: insights from cardiac magnetic resonance imaging and invasive haemodynamics. Eur J Heart Fail. 2016 Jan; 18(1):71-80. PMID: 26449727.
    Citations:    
  38. Zotter-Tufaro C, Duca F, Kammerlander AA, Koell B, Aschauer S, Dalos D, Mascherbauer J, Bonderman D. Diastolic Pressure Gradient Predicts Outcome in Patients With Heart Failure and Preserved Ejection Fraction. J Am Coll Cardiol. 2015 Sep 15; 66(11):1308-1310. PMID: 26361165.
    Citations:    
  39. Karakus G, Kammerlander AA, Aschauer S, Marzluf BA, Zotter-Tufaro C, Bachmann A, Degirmencioglu A, Duca F, Babayev J, Pfaffenberger S, Bonderman D, Mascherbauer J. Pulmonary artery to aorta ratio for the detection of pulmonary hypertension: cardiovascular magnetic resonance and invasive hemodynamics in heart failure with preserved ejection fraction. J Cardiovasc Magn Reson. 2015 Aug 30; 17:79. PMID: 26318496.
    Citations:    
  40. Mascherbauer J, Kammerlander AA, Marzluf BA, Graf A, Kocher A, Bonderman D. Prognostic Impact of Tricuspid Regurgitation in Patients Undergoing Aortic Valve Surgery for Aortic Stenosis. PLoS One. 2015; 10(8):e0136024. PMID: 26291082.
    Citations:    
  41. Goliasch G, Zotter-Tufaro C, Aschauer S, Duca F, Koell B, Kammerlander AA, Ristl R, Lang IM, Maurer G, Mascherbauer J, Bonderman D. Outcome in Heart Failure with Preserved Ejection Fraction: The Role of Myocardial Structure and Right Ventricular Performance. PLoS One. 2015; 10(7):e0134479. PMID: 26225557.
    Citations:    
  42. Zotter-Tufaro C, Mascherbauer J, Duca F, Koell B, Aschauer S, Kammerlander AA, Panzenboeck A, Sadushi-Kolici R, Bangert C, Laimer D, Ristl R, Lang IM, Bonderman D. Prognostic Significance and Determinants of the 6-Min Walk Test in Patients With Heart Failure and Preserved Ejection Fraction. JACC Heart Fail. 2015 Jun; 3(6):459-466. PMID: 26046839.
    Citations:    
  43. Mangold A, Alias S, Scherz T, Hofbauer T, Jakowitsch J, Panzenböck A, Simon D, Laimer D, Bangert C, Kammerlander A, Mascherbauer J, Winter MP, Distelmaier K, Adlbrecht C, Preissner KT, Lang IM. Coronary neutrophil extracellular trap burden and deoxyribonuclease activity in ST-elevation acute coronary syndrome are predictors of ST-segment resolution and infarct size. Circ Res. 2015 Mar 27; 116(7):1182-92. PMID: 25547404.
    Citations:    
  44. Kammerlander AA, Marzluf BA, Graf A, Bachmann A, Kocher A, Bonderman D, Mascherbauer J. Right ventricular dysfunction, but not tricuspid regurgitation, is associated with outcome late after left heart valve procedure. J Am Coll Cardiol. 2014 Dec 23; 64(24):2633-2642. PMID: 25524343.
    Citations:    
  45. Bonderman D, Graf A, Kammerlander AA, Kocher A, Laufer G, Lang IM, Mascherbauer J. Factors determining patient-prosthesis mismatch after aortic valve replacement--a prospective cohort study. PLoS One. 2013; 8(12):e81940. PMID: 24312608.
    Citations:    
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Kammerlander's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (159)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.